14 Services Across the Biologics Development Lifecycle

From early process design through scale-up and transfer, these services cover the full breadth of laboratory and development needs for biological products — executed with practitioner-grade rigour and a clear eye toward regulatory readiness.

01

Process Development and Optimization

Process-development support for biologics, proteins, extracellular vesicles and other complex biological products. Services include process design, parameter screening, recovery and yield optimization, impurity-reduction strategies, scale-up planning, process troubleshooting and technology-transfer preparation.

Process Design Scale-Up Yield Optimization
02

Tangential Flow Filtration

Multi-scale tangential flow filtration development for concentration, diafiltration and buffer exchange. Services include membrane and molecular-weight-cutoff selection, operating-parameter optimization, flux and recovery assessment, fouling evaluation, mass balance, scale-up recommendations and integration with downstream purification.

TFF Diafiltration Concentration
03

Filtration Development and Filter Testing

Filtration studies supporting clarification, bioburden reduction, sterile-filtration development and process-scale selection. Services include filter screening, throughput and capacity evaluation, pressure and flux assessment, product-recovery testing, adsorption-risk evaluation and prefilter/final-filter strategy development.

Sterile Filtration Filter Screening Clarification
04

Protein Purification and Chromatography

Small-scale protein purification and FPLC chromatography development using affinity, ion-exchange, size-exclusion, hydrophobic-interaction and multimodal approaches. Services include resin screening, capture and polishing development, impurity clearance, recovery assessment, fraction analysis and scale-up recommendations.

FPLC Affinity Ion Exchange SEC
05

Extracellular Vesicle Purification

Purification and concentration development for mammalian- and microbial-derived extracellular vesicles. Services may include centrifugation, TFF, filtration and chromatography-based workflows, with assessment of particle recovery, size distribution, aggregation, protein and nucleic-acid impurities, endotoxin and formulation stability.

EVs Exosomes Nanoparticles
06

Formulation and Buffer Development

Formulation and buffer-development support for proteins, biologics and extracellular vesicles. Services include buffer preparation, pH and osmolality optimization, excipient screening, concentration studies, freeze–thaw assessment, hold-time evaluation, compatibility studies and preparation of materials for stability testing.

Buffer Optimization Excipient Screening Stability
07

Lyophilization Development

Lyophilization development for proteins, biologics, extracellular vesicles and research-use materials. Services include formulation screening, cryoprotectant and lyoprotectant selection, freeze-drying cycle development, reconstitution assessment, cake-quality evaluation and pre-/post-lyophilization comparability testing.

Freeze-Drying Cryoprotectants Cake Quality
08

Protein Characterization

Analytical characterization of proteins and biologics using SDS-PAGE, Western blotting, thermal-shift assays and differential scanning calorimetry. Studies can support identity assessment, purity and degradation evaluation, thermal stability, formulation screening, process comparability and troubleshooting.

SDS-PAGE Western Blot DSC TSA
09

Particle Size and Zeta-Potential Analysis

Zetasizer-based characterization of particle size, polydispersity and zeta potential for extracellular vesicles, nanoparticles, protein formulations and other dispersed systems. Testing can support formulation selection, aggregation assessment, process comparison, freeze–thaw studies and stability evaluation.

DLS Zeta Potential PDI
10

qPCR and Nucleic-Acid Testing

qPCR-based analytical support for process development and biological-product characterization. Applications may include target detection, relative quantification, residual nucleic-acid assessment, process-comparison studies and evaluation of nucleic-acid recovery across purification steps.

qPCR Residual DNA Quantification
11

Endotoxin Testing and Method Support

Endotoxin testing and method-development support for biologics, proteins, extracellular vesicles, buffers and process samples. Services include sample suitability, dilution and interference evaluation, spike-recovery studies, process monitoring and investigation of formulation-related inhibition or enhancement.

LAL Assay Spike Recovery Method Development
12

Cell Culture and Metabolite Analysis

Cell-culture monitoring using Cedex metabolite analysis and NucleoCounter-based cell counting. Testing can include viable cell concentration, viability and key metabolite measurements to support culture monitoring, harvest-time decisions, process comparison, troubleshooting and scale-up studies.

Cedex NucleoCounter Viability Metabolites
13

Compendial and General Analytical Testing

Compendial and general analytical testing support for development-stage biological products and formulations. Available measurements include pH, osmolality, appearance and other applicable physicochemical tests. Services can support method feasibility, formulation comparison, stability studies and analytical testing-plan development.

pH Osmolality Physicochemical
14

Process Comparability and Technology Transfer

Technical support for process changes, scale-up and transfer between laboratories, manufacturers or CDMOs. Services include process-gap assessment, equipment and parameter comparison, analytical comparability planning, risk assessment, protocol development, data review and preparation of practical transfer documentation.

Comparability CDMO Transfer Risk Assessment

Ready to discuss your project?

Whether you need a single analytical method or end-to-end downstream process development, reach out for a no-obligation scoping conversation.